• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Retrospective audit of different antenatal screening policies for Down's syndrome in eight district general hospitals in one health region.对某一卫生区域内八家区综合医院唐氏综合征不同产前筛查政策的回顾性审计。
BMJ. 2002 Jul 6;325(7354):15. doi: 10.1136/bmj.325.7354.15.
2
Six year survey of screening for Down's syndrome by maternal age and mid-trimester ultrasound scans.基于孕妇年龄和孕中期超声扫描对唐氏综合征进行筛查的六年调查。
BMJ. 2000 Mar 4;320(7235):606-10. doi: 10.1136/bmj.320.7235.606.
3
SURUSS in perspective.透视下的SURUSS。
BJOG. 2004 Jun;111(6):521-31. doi: 10.1111/j.1471-0528.2004.00193.x.
4
SURUSS in perspective.透视下的SURUSS
Semin Perinatol. 2005 Aug;29(4):225-35. doi: 10.1053/j.semperi.2005.05.006.
5
Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). The Brighton and Eastbourne Down's Syndrome Screening Group.在两个地区(布莱顿和伊斯特本)实施唐氏综合征产前血清筛查项目。布莱顿和伊斯特本唐氏综合征筛查小组。
J Med Screen. 1994 Jan;1(1):45-9. doi: 10.1177/096914139400100109.
6
Using decision analysis to compare policies for antenatal screening for Down's syndrome.运用决策分析比较唐氏综合征产前筛查策略。
BMJ. 1995 Aug 5;311(7001):351-6. doi: 10.1136/bmj.311.7001.351.
7
Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.唐氏综合征的产前母体血清筛查:一个示范项目的结果
BMJ. 1992 Aug 15;305(6850):391-4. doi: 10.1136/bmj.305.6850.391.
8
Prenatal screening for Down's syndrome with use of maternal serum markers.使用母体血清标志物进行唐氏综合征的产前筛查。
N Engl J Med. 1992 Aug 27;327(9):588-93. doi: 10.1056/NEJM199208273270902.
9
Effect of routine screening for Down's syndrome on the significance of isolated fetal hydronephrosis.
Br J Obstet Gynaecol. 1998 Aug;105(8):860-4. doi: 10.1111/j.1471-0528.1998.tb10230.x.
10
Strategies for antenatal detection of Down's syndrome.唐氏综合征产前检测策略。
Arch Dis Child Fetal Neonatal Ed. 1997 Jan;76(1):F26-30. doi: 10.1136/fn.76.1.f26.

引用本文的文献

1
The importance of rapid aneuploidy screening and prenatal diagnosis in the detection of numerical chromosomal abnormalities.快速非整倍体筛查和产前诊断在检测染色体数目异常中的重要性。
Springerplus. 2013 Sep 29;2:490. doi: 10.1186/2193-1801-2-490. eCollection 2013.
2
A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000.1981 - 2000年法国基于人群的唐氏综合征产前筛查影响评估
BJOG. 2004 May;111(5):485-90. doi: 10.1111/j.1471-0528.2004.00117.x.
3
Antenatal screening policies for Down's syndrome. Audit of Down's syndrome screening is not valid.唐氏综合征的产前筛查政策。唐氏综合征筛查的审计无效。
BMJ. 2002 Nov 2;325(7371):1034; author reply 1034.

本文引用的文献

1
Six year survey of screening for Down's syndrome by maternal age and mid-trimester ultrasound scans.基于孕妇年龄和孕中期超声扫描对唐氏综合征进行筛查的六年调查。
BMJ. 2000 Mar 4;320(7235):606-10. doi: 10.1136/bmj.320.7235.606.
2
Antenatal screening for Down's syndrome.唐氏综合征的产前筛查
Health Technol Assess. 1998;2(1):i-iv, 1-112.
3
A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.一项使用孕妇血清甲胎蛋白、人绒毛膜促性腺激素和未结合雌三醇对孕中期胎儿唐氏综合征进行筛查试验的前瞻性评估。
Obstet Gynecol. 1993 Jan;81(1):72-7.
4
Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme.孕中期使用甲胎蛋白、人绒毛膜促性腺激素和游离雌三醇进行母体血清筛查:一项区域计划的经验。
Prenat Diagn. 1994 May;14(5):391-402. doi: 10.1002/pd.1970140509.
5
Down's syndrome. Recent trends in the United States.
JAMA. 1981 Aug 14;246(7):758-60. doi: 10.1001/jama.246.7.758.
6
Results of first year (1989) of a national register of Down's syndrome in England and Wales.英格兰和威尔士唐氏综合征国家登记处第一年(1989年)的结果。
BMJ. 1991 Nov 23;303(6813):1295-7. doi: 10.1136/bmj.303.6813.1295.

对某一卫生区域内八家区综合医院唐氏综合征不同产前筛查政策的回顾性审计。

Retrospective audit of different antenatal screening policies for Down's syndrome in eight district general hospitals in one health region.

作者信息

Wellesley Diana, Boyle Tracy, Barber John, Howe David T

机构信息

Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton SO16 5YA.

出版信息

BMJ. 2002 Jul 6;325(7354):15. doi: 10.1136/bmj.325.7354.15.

DOI:10.1136/bmj.325.7354.15
PMID:12098722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC116665/
Abstract

OBJECTIVE

To compare the effectiveness of different screening policies for the antenatal detection of Down's syndrome.

DESIGN

Retrospective six year survey.

SETTING

Maternity units of eight districts.

PARTICIPANTS

Women who completed their pregnancies between 1 January 1994 and 31 December 1999 (155 501 deliveries).

MAIN OUTCOME MEASURES

Cases of Down's syndrome identified before 24 weeks' gestation.

RESULTS

335 cases of Down's syndrome were identified, 323 in continuing pregnancies or liveborn children. Of these, 171 were identified antenatally. Seven different screening policies were used, in three principal groups: serum screening offered to all mothers, maternal age with serum screening or nuchal translucency available to limited groups, and maternal age combined with anomaly scans. The districts that used serum screening detected 57%, those using maternal age plus serum or nuchal translucency screening 52%, and those using a maternal age of > or =35 and anomaly scans detected 54%. The least successful district, which offered amniocentesis only to women aged over 37 years, detected only 31%. If amniocentesis had been offered from 35 years, as in all other districts, the detection rate would have risen to 54%. Across the region 15% (range 12-20%) of pregnant women were 35 years or more at delivery, and 58% (33-69%) of infants with Down's syndrome were born to women in this age range.

CONCLUSIONS

Current additional serum or nuchal translucency screening techniques for antenatal detection of Down's syndrome are less advantageous than previously supposed. More pregnant women were aged over 35 than has been presumed in statistical models used in demonstration projects of serum screening and, as a result, the proportion of affected fetuses in this age group is much greater than predicted.

摘要

目的

比较不同唐氏综合征产前筛查策略的有效性。

设计

回顾性六年调查。

地点

八个区的产科病房。

参与者

在1994年1月1日至1999年12月31日期间完成妊娠的妇女(155501例分娩)。

主要观察指标

孕24周前确诊的唐氏综合征病例。

结果

共确诊335例唐氏综合征,其中323例为继续妊娠或活产儿。其中,171例为产前确诊。采用了七种不同的筛查策略,主要分为三组:对所有母亲进行血清筛查;对有限人群提供结合血清筛查或颈部透明带扫描的母亲年龄筛查;母亲年龄结合超声结构畸形筛查。采用血清筛查的地区检出率为57%,采用母亲年龄加血清或颈部透明带筛查的地区为52%,采用母亲年龄≥35岁并结合超声结构畸形筛查的地区为54%。最不成功的地区仅对37岁以上妇女进行羊水穿刺检查,检出率仅为31%。如果像其他所有地区一样从35岁开始提供羊水穿刺检查,检出率将升至54%。在该地区,15%(范围12 - 20%)的孕妇分娩时年龄在35岁及以上,58%(33 - 69%)的唐氏综合征婴儿出生于这个年龄范围的妇女。

结论

目前用于唐氏综合征产前检测的血清或颈部透明带附加筛查技术的优势不如先前认为的那样明显。年龄超过35岁的孕妇比血清筛查示范项目中使用的统计模型所假设的更多,因此,该年龄组中受影响胎儿的比例远高于预期。